Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation

Combination of maternal factors and biomarkers in the early third trimester could predict nearly all cases of preterm-PE and half of those with term-PE, at 5% false-positive rate.